Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
Intracoronary Bradykinin Mediated t-PA Release in Heart Transplant Recipients
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2017-03-20
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00780377
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Brachial Artery t-PA Release in Heart Transplant Recipients
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2016-07-15
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00780637
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Metabolic Adaptations to Diabetes in African Americans
Not Applicable
Completed
- Conditions
- Diabetes
- Interventions
- Procedure: glucose clamp
- First Posted Date
- 2008-10-27
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 16
- Registration Number
- NCT00780195
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Phase 4
Completed
- Conditions
- Metabolic Syndrome
- Interventions
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 46
- Registration Number
- NCT00775671
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Project Diabetes: Prescription for Healthy Living
Not Applicable
Terminated
- Conditions
- Type 2 Diabetes MellitusBehavioral ResearchExerciseObesity
- Interventions
- Behavioral: Behavioral counseling plus "telephone helpline"
- First Posted Date
- 2008-10-20
- Last Posted Date
- 2015-05-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 13
- Registration Number
- NCT00775216
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effect of Exercise in OI
Not Applicable
Completed
- Conditions
- Orthostatic IntolerancePostural Tachycardia Syndrome
- Interventions
- Drug: Placebo then Propranolol
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2016-08-05
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 12
- Registration Number
- NCT00770484
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery
Phase 2
Withdrawn
- Conditions
- Congenital Heart Disease
- Interventions
- Other: Standard surgical approach
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT00770705
- Locations
- 🇺🇸
Vanderbilt Children's Hospital, Nashville, Tennessee, United States
The Effects of Pentoxifylline on PAI-1 in an Obese Population
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2017-11-30
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 37
- Registration Number
- NCT00770328
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Ghrelin Changes After Roux-en-Y Gastric Bypass
Completed
- Conditions
- ObesityInsulin Resistance
- Interventions
- Other: Liquid diet for 3 days
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2011-11-17
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 14
- Registration Number
- NCT00765596
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Validation of an Assay to Measure Cyclooxygenase-1 Activity
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Other: Chewable aspirin
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 64
- Registration Number
- NCT00761891
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath